Academic Bibliography

Search 200 years of publications by Ghent University researchers.

dr. Sandra Van Lint

Faculty of Medicine and Health Sciences > Department of Biomolecular Medicine

Work address: Albert Baertsoenkaai 3
9000 Gent
Email: Sandra.VanLint@UGent.be

Show Sort by

Add to list
- Journal Article
- A1
- open access
The opposing effect of type I IFN on the T cell response by non-modified mRNA-lipoplex vaccines Is determined by the route of administration

Lien Van Hoecke (UGent) , Kenny Roose (UGent) , Marlies Ballegeer (UGent) , Zifu Zhong (UGent) , Niek Sanders (UGent) , Stefaan De Koker (UGent) , Xavier Saelens (UGent) and Sandra Van Lint (UGent)

(2020) MOLECULAR THERAPY-NUCLEIC ACIDS. 22(4). p.373-381
Add to list
- Journal Article
- A1
- open access
Specific targeting of IL-1β activity to CD8+ T cells allows for safe use as a vaccine adjuvant

Bram Van Den Eeckhout (UGent) , Lien Van Hoecke (UGent) , Elianne Burg (UGent) , Sandra Van Lint (UGent) , Frank Peelman (UGent) , Niko Kley, Gilles Uzé, Xavier Saelens (UGent) , Jan Tavernier (UGent) and Sarah Gerlo (UGent)

(2020) NPJ VACCINES. 5(1).
Add to list
- Conference Paper
- C3
Selected IL-1 activity on CD8+ T cells allows for safe enhancement of cellular immune responses

Bram Van Den Eeckhout (UGent) , Lien Van Hoecke (UGent) , Elianne Burg (UGent) , Sandra Van Lint (UGent) , Frank Peelman (UGent) , Niko Kley, Gilles Uzé, Xavier Saelens (UGent) , Jan Tavernier (UGent) and Sarah Gerlo (UGent)

(2020) T Cell Memory, Abstracts.
Add to list
- Journal Article
- A1
- open access
Safe eradication of large established tumors using neovasculature-targeted tumor necrosis factor-based therapies

Leander Huyghe (UGent) , Alexander Van Parys (UGent) , Anje Cauwels (UGent) , Sandra Van Lint (UGent) , Stijn De Munter (UGent) , Jennyfer Bultinck (UGent) , Lennart Zabeau (UGent) , Jeroen Hostens, An Goethals, Nele Vanderroost (UGent) , et al.

(2020) EMBO MOLECULAR MEDICINE. 12(2).
Add to list
- Conference Paper
- C3
Towards the use of interleukin-1β as vaccine adjuvant

Bram Van Den Eeckhout (UGent) , Lien Van Hoecke (UGent) , Elianne Burg (UGent) , Sandra Van Lint (UGent) , Frank Peelman (UGent) , Xavier Saelens (UGent) , Jan Tavernier (UGent) and Sarah Gerlo (UGent)

(2019) The 1918 influenza pandemic: historical and biomedical reflections, VIB conference, Abstracts.
Add to list
Targeting interferon activity to dendritic cells enables in vivo tolerization and protection against EAE in mice

Anje Cauwels (UGent) , Sandra Van Lint (UGent) , Dominiek Catteeuw (UGent) , Shengru Pang, Franciane Paul, Elke Rogge (UGent) , Annick Verhee (UGent) , Marco Prinz, Niko Kley, Gilles Uzé, et al.

(2019) JOURNAL OF AUTOIMMUNITY. 97. p.70-76
Add to list
- Conference Paper
- C3
IL-1β AcTaleukins : towards potent yet safe adjuvants for tumor vaccination

Bram Van Den Eeckhout (UGent) , Elianne Burg (UGent) , Anje Cauwels (UGent) , Frank Peelman (UGent) , Sandra Van Lint (UGent) , Jan Tavernier (UGent) and Sarah Gerlo (UGent)

(2018) Dendritic Cells, 15th International symposium, Abstracts.
Add to list
Nanoparticle-conjugate TLR7/8 agonist localized immunotherapy provokes safe antitumoral responses

Lutz Nuhn (UGent) , Stefaan De Koker (UGent) , Sandra Van Lint (UGent) , Zifu Zhong (UGent) , João Portela Catani (UGent) , Francis Combes (UGent) , Kim Deswarte (UGent) , Yupeng Li, Bart Lambrecht (UGent) , Stefan Lienenklaus, et al.

(2018) ADVANCED MATERIALS. 30(45).
Add to list
- Journal Article
- A1
- open access
Treatment with mRNA coding for the necroptosis mediator MLKL induces antitumor immunity directed against neo-epitopes

Lien Van Hoecke (UGent) , Sandra Van Lint (UGent) , Kenny Roose (UGent) , Alexander Van Parys (UGent) , Peter Vandenabeele (UGent) , Johan Grooten (UGent) , Jan Tavernier (UGent) , Stefaan De Koker (UGent) and Xavier Saelens (UGent)

(2018) NATURE COMMUNICATIONS. 9.
Add to list
Delivering type I interferon to dendritic cells empowers tumor eradication and immune combination treatments

Anje Cauwels (UGent) , Sandra Van Lint (UGent) , Franciane Paul, Genevieve Garcin, Stefaan De Koker (UGent) , Alexander Van Parys (UGent) , Thomas Wüest (UGent) , Sarah Gerlo (UGent) , José Van Der Heyden (UGent) , Yan Bordat, et al.

(2018) CANCER RESEARCH. 78(2). p.463-474

1
2
3
4

Next →